Alcon Targets India for Major Expansion Amid Rising Myopia Cases
Alcon plans significant investments in India, focusing on innovation and training to meet growing eye care demands.
Alcon, a global leader in eye care devices, is intensifying its focus on India, eyeing the country as a key growth market. The Swiss-American company aims to capitalize on the increasing demand for eye care among younger populations, particularly with the rise in myopia and dry eye disease due to prolonged screen exposure.
Expanding Presence and Investment in India
Alcon's strategy involves deepening investments in innovation and surgeon training, as well as strengthening partnerships with eye care hospitals. Rajkumar Narayanan, Senior Vice President of Alcon, highlighted the importance of India and China as pivotal emerging markets for the company. Alcon is considering future manufacturing opportunities in India to bolster its global footprint.
India serves as a central hub for Alcon's training and education initiatives, such as the Phaco Development Program, which trains young cataract surgeons. The company has also established a global capability center in India, making it the second-largest base for Alcon employees outside the United States.
Addressing Rising Eye Disorders Among Youth
The increasing prevalence of myopia and dry eye disease among Gen Z and Gen Alpha is a significant growth driver for Alcon. Data indicates that around 23% of school children in India are myopic, with dry eye prevalence estimates ranging between 25% and 58%. This trend is attributed to lifestyle changes, including more screen time and less outdoor activity.
Alcon plans to enhance access to advanced cataract care for up to 6 million people in India by 2030 through innovation, education, and strategic partnerships. The company's presence in the Indian market spans two main franchises: surgical and vision care, offering a comprehensive range of ophthalmic products and services.
Comparative Market Dynamics: India vs. China
India's ophthalmology market is notably different from China's, with a higher number of cataract surgeries performed annually. India's market benefits from greater awareness and a predominantly private care model, allowing faster introduction of innovations due to quicker regulatory approvals. In contrast, China's public healthcare system focuses on cost control, presenting a different set of opportunities and challenges.
Alcon's strategic initiatives in India aim to address the growing eye care needs and position the company as a leader in the region's rapidly expanding ophthalmology market.